Author

A. Lujambio

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

A. de Pablos· 1 shared A. M. Tsankov· 1 shared B. Giotti· 1 shared D. H. Gutmann· 1 shared D. Hambardzumyan· 1 shared D. J. Eddins· 1 shared D. Pal· 1 shared D. Zeltsman· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. de Pablos

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Integrated in vivo functional screens and multi-omics analyses identify alpha-2,3-sialylation as essential for melanoma maintenance

P. Agrawal, S. Chen, A. de Pablos, F. Jame-Chenarboo, E. Miera Saenz de Vega, F. Darvishian, I. Osman, A. Lujambio, L. K. Mahal, E. Hernando

bioRxiv · Mar 8, 2024 · PreprintCancer Biology

The novel compensatory reciprocal interplay between neutrophils and monocytes drives cancer progression

Z. Chen, N. Soni, G. Pinero, B. Giotti, D. J. Eddins, K. E. Lindblad, J. L. Ross, N. Tsankova, D. H. Gutmann, S. Lira, A. Lujambio, E. E. B. Ghosn, A. M. Tsankov, D. Hambardzumyan

This paper shows that eliminating monocyte chemoattraction increases neutrophil infiltration in glioblastoma, promoting tumor aggression, and that targeting both monocytes and neutrophils improves survival in mouse models.

bioRxiv · Jul 21, 2022 · PreprintImmunology

An epigenetic switch regulates the ontogeny of AXL positive/EGFR-TKI resistant cells by modulating miR-335 expression

R. Sordella, D. Pal, P. Safaric Tepes, T. Lindsted, I. Ibarra, A. Lujambio, V. Jimenez Sabinina, S. Senturk, M. Miller, N. Korimerla, J. Huang, L. Glassman, P. Lee, D. Zeltsman, K. Hyman, , G. Hannon

The paper identifies an epigenetic mechanism regulating AXL-positive/Erlotinib-resistant cells through miR-335 expression, suggesting combinatorial therapies for EGFR-mutated NSCLC.

bioRxiv · Jan 6, 2021Cancer Biology